| 注册
首页|期刊导航|中国临床药学杂志|舍曲林血药浓度影响因素研究进展

舍曲林血药浓度影响因素研究进展

自雪梅 王晶晶

中国临床药学杂志2025,Vol.34Issue(6):476-480,5.
中国临床药学杂志2025,Vol.34Issue(6):476-480,5.DOI:10.19577/j.1007-4406.2025.06.015

舍曲林血药浓度影响因素研究进展

Research progress on influencing factors of sertraline blood concentration

自雪梅 1王晶晶2

作者信息

  • 1. 楚雄彝族自治州人民医院临床研究中心,楚雄 675000
  • 2. 昆明医科大学第一附属医院临床医学研究中心,昆明 650032
  • 折叠

摘要

Abstract

As a potent and selective serotonin reuptake inhibitor(SSRI)widely used in clinical practice,sertraline has significant inter-individual differences in its steady-state plasma concentration under conventional doses.This difference stems from multifactorial effects,including dose,age,liver function status,concomitant medication status,and drug metabolism-related factors such as genetic polymorphisms.This review systematically analyzed the key factors affecting sertraline blood concentration(including dose,demographic characteristics,physiopathological status,and drug interactions),aiming to provide evidence-based basis for the clinical formulation of individualized dosing regimens,so as to optimize the treatment effect and ensure drug safety.

关键词

舍曲林/血药浓度/影响因素

Key words

sertraline/blood drug concentration/influencing factor

分类

医药卫生

引用本文复制引用

自雪梅,王晶晶..舍曲林血药浓度影响因素研究进展[J].中国临床药学杂志,2025,34(6):476-480,5.

基金项目

国家自然科学基金(编号82460737) (编号82460737)

云南省应用基础研究-昆明医科大学联合专项(编号202401AY070001-034) (编号202401AY070001-034)

中国临床药学杂志

1007-4406

访问量0
|
下载量0
段落导航相关论文